![Anthony G. Johnson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony G. Johnson
Direktor/Vorstandsmitglied bei NanoSyrinx Ltd
Ursprung des Netzwerks ersten Grades von Anthony G. Johnson
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
NanoSyrinx Ltd
![]() NanoSyrinx Ltd Miscellaneous Commercial ServicesCommercial Services NanoSyrinx Ltd is a discovery stage biotechnology company that is based in the UK. The British company is focused on developing protein nanosyringes as a new way to deliver protein and peptide biologic drugs intracellularly. The company uses synthetic biology approaches to achieve this goal. The company was founded by Joseph Healey, Alexia Hapeshi, and Nicholas Waterfield, with Joseph Healey serving as the CEO since incorporation.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Domain Therapeutics SA
![]() Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France.
2
| Holding Company | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anthony G. Johnson
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Biotechnology | Director/Board Member Chief Executive Officer | |
Alsace BioValley Association
![]() Alsace BioValley Association Medical/Nursing ServicesHealth Services Alsace BioValley Association operates as a health innovation center. The private company is based in Illkirch, France. | Medical/Nursing Services | President | |
Dark Blue Therapeutics Ltd.
![]() Dark Blue Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Dark Blue Therapeutics Ltd. operates as a biotechnology firm. The company was founded in June 4, 2020 an is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Institute of Corporate Directors
![]() Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
adMare Bioinnovations
![]() adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | ||
Neurasic Therapeutics, Inc.
![]() Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neurasic Therapeutics, Inc. develops opiate-sparing and pain-relieving drugs. The company was founded in June 2020 and is headquartered in Westmount, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
CTI Life Sciences Fund
![]() CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services CTI Life Sciences Fund provides life science related services. The private company is based in Montréal, Canada. The Canadian company was founded in 2006 by Kenneth Pastor. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Fast BioPharma Ltd.
![]() Fast BioPharma Ltd. Miscellaneous Commercial ServicesCommercial Services Fast BioPharma Ltd. develops therapeutic products for treatment of cancer. The company is headquartered in Watlington, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
BioCity Group Ltd
![]() BioCity Group Ltd Investment ManagersFinance BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Rinri Therapeutics Ltd.
![]() Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Oxford Science Enterprises PLC
![]() Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Investor | |
Kinomica Ltd.
![]() Kinomica Ltd. BiotechnologyHealth Technology Kinomica Ltd. develops anti-cancer drug therapies. The company is based in Macclesfield, UK. The British company was founded in 2016 by David Britton, Pedro Rodriguez Cutillas. The CEO is Jane Theaker. | Biotechnology | Director/Board Member | |
Domain Therapeutics Na, Inc. | Chairman | ||
metaLinear Ltd.
![]() metaLinear Ltd. Miscellaneous Commercial ServicesCommercial Services metaLinear Ltd. operates as a biotechnology firm. It uses proteome engineering technology to identify, validate, and drug new microbial targets. The company was founded by Paul Ko Ferrigno in November 2016 and is headquartered in Cheshire, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
We Are Pioneer Group Ltd.
![]() We Are Pioneer Group Ltd. Investment ManagersFinance We Are Pioneer Group Ltd. (Pioneer Group) is a venture capital firm founded in 2021. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Private Equity Investor | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
UCB Research, Inc.
![]() UCB Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, UCB Research, Inc. is a company that provides commercial physical research laboratory services. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Glasgow Singapore | College/University | Undergraduate Degree | |
Glasgow Caledonian University | College/University | Doctorate Degree | |
Loughborough University | College/University | Masters Business Admin | |
Alethiomics Ltd.
![]() Alethiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Alethiomics Ltd. operates as a British biotechnology company. The company is based in Cambridge, UK. The company was founded in 2021 by Adam Joseph Mead, Bethan Psaila. The CEO is Mark Throsby. | Miscellaneous Commercial Services | Director/Board Member | |
The Scripps Research Institute
![]() The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Graduate Degree | |
Lake Forest Graduate School of Management | College/University | Masters Business Admin | |
BELLUS HEALTH | Pharmaceuticals: Major | Director/Board Member | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
![]() F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Corporate Officer/Principal | |
TRANSGENE | Biotechnology | Corporate Officer/Principal | |
University of Strasbourg | College/University | Doctorate Degree | |
Axilum Robotics SAS
![]() Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France. | Miscellaneous Commercial Services | Chairman | |
Peptimimesis SAS
![]() Peptimimesis SAS BiotechnologyHealth Technology Peptimimesis SAS provides biotechnology research services. Its platform delivers a set of drug candidates that act on strategic targets in the field of immuno-oncology, oncology, and immune diseases. The company was founded by Dominique Bagnard and Pascal Neuville in October 2015 and is headquartered in Strasbourg, France. | Biotechnology | Founder | |
Mavalon Therapeutics Ltd.
![]() Mavalon Therapeutics Ltd. Medical SpecialtiesHealth Technology Mavalon Therapeutics Ltd. develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients. The company is headquartered in Hatfield, the United Kingdom. | Medical Specialties | Director/Board Member | |
Cellzome Ltd.
![]() Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree | |
MedImmune Ltd.
![]() MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
AgrEvo GmbH
![]() AgrEvo GmbH Chemicals: AgriculturalProcess Industries AgrEvo GmbH manufacturers fertilizer products. It offers crop protection and production products including seeds, pest control products and other bio- technology products. The company is headquartered in Berlin, Germany. | Chemicals: Agricultural | Corporate Officer/Principal | |
Pharmenable Ltd.
![]() Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
University of Geneva | College/University | Corporate Officer/Principal | |
Macomics Ltd.
![]() Macomics Ltd. Miscellaneous Commercial ServicesCommercial Services Macomics Ltd. engages in research and experimental development on biotechnology. The company was founded by Jeffrey William Pollard and Luca Cassetta on November 6, 2018 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Elasmogen Ltd.
![]() Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Cambridge Judge Business School | College/University | Masters Business Admin | |
Spirea Ltd.
![]() Spirea Ltd. BiotechnologyHealth Technology Spirea Ltd. operates as a healthcare technology company. It develops smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines. The company was founded by Myriam Ouberai and is headquartered in arrogate, the United Kingdom. | Biotechnology | Director/Board Member | |
Vertex Pharmaceuticals (Canada), Inc.
![]() Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
ATHERSYS, INC. | Biotechnology | Corporate Officer/Principal | |
ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Montréal | College/University | Doctorate Degree | |
AlveoGene Ltd.
![]() AlveoGene Ltd. Financial ConglomeratesFinance AlveoGene Ltd. is a British dormant company that was founded in 2022. The company is based in Oxford, UK. | Financial Conglomerates | Director/Board Member |
Statistik
International
Vereinigtes Königreich | 23 |
Kanada | 11 |
Vereinigte Staaten | 9 |
Frankreich | 6 |
Singapur | 2 |
Sektoral
Health Technology | 22 |
Commercial Services | 11 |
Consumer Services | 11 |
Finance | 5 |
Health Services | 2 |
Operativ
Director/Board Member | 19 |
Corporate Officer/Principal | 15 |
Chairman | 7 |
Chief Executive Officer | 4 |
Founder | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Anthony G. Johnson
- Unternehmensverbindungen